Browse

It's tough to write nuanced headlines, but a new study on AI in emergency rooms is getting way overhyped.

A new flavor of company is shaking up how biotechs are built. Instead of launching with eye-popping early-stage science or a new platform, there's a surge of startups with small teams, large checks…

A second shot at gene therapy for Huntington's, China's tightening grip on pharma supply chains, and more Readout biotech updates